Winter and the long-anticipated rollout of coronavirus vaccines triggered some surprising shifts in Bloomberg’s Covid Resilience Ranking, a measure of the best places to be in the Covid-19 era.
Each month, we crunch the numbers to get a snapshot of where the virus is being handled the most effectively with the least social and economic disruption.
New Zealand—with its closed borders, vaccine deals and elimination of the virus in the community—remains No. 1 in December, with Taiwan edging into second place as the onset of cold weather challenges previously top-ranked places like Japan and South Korea.
The winter wave’s ferocity is testing their approach of trying to tame Covid-19 without locking down. Japan—No. 2 in November—Korea and Sweden have all fallen in the Ranking as people’s migration indoors fuels the virus’s spread, putting pressure on their long-standing strategies of suppressing the pathogen with minimal disruption. Lauded for its early focus on testing and cutting-edge contact tracing, Korea is trying to avoid imposing its toughest curbs yet.
Read about the methodology behind the Bloomberg Covid Resilience Ranking here
Winter in the northern hemisphere has made a bad situation worse across Europe and the U.S., with the superpower plunging 19 spots despite the rapid authorization of two mRNA vaccines.
Mexico remains at No. 53, the last of the ranked economies. The country is closing the gap with other places as its positive testing rate falls and it lines up inoculations, but it’s still facing a rampant outbreak.
The Ranking scores economies of more than $200 billion on 10 key metrics: from growth in virus cases to the overall mortality rate and testing capabilities. The capacity of the local health-care system, the impact of virus-related restrictions like lockdowns on the economy, and freedom of movement are also taken into account.
For December, Bloomberg refreshed the Access to Covid Vaccines metric as more information emerges on order sizes, shifting from tracking the number of vaccine deals to the percentage of a population covered by agreements.
The U.K., the first country in the world to give emergency authorization to the Pfizer Inc.-BioNTech SE shot in early December, has still fallen two rungs from November. While its vaccine orders cover nearly 300% of the British population, distribution has only just begun and an unbridled outbreak has forced London and surrounding areas into an unprecedented lockdown through Christmas.
The U.S.’s steep drop in rank reflects the perils of a vaccine-reliant strategy. It has authorized two cutting-edge mRNA vaccines this month and hundreds of thousands of doses have been rolled out, but that is yet to translate to an easing of the devastation on the ground. The death toll has surged with one American dying every 41 seconds of Covid-19 over the past month, and hospitals near capacity in many states.
Also weighing on the U.S. is the fact its vaccine orders so far cover a smaller percentage of the country’s population than places like Canada and the European Union: 154%. Though the government says it will have enough supply for 20 million people by year-end, distribution across the 50 states looks uneven and it will be weeks before broader protection materializes in the population.
How quickly and effectively vaccination can stem the virus’s spread will be the key focus into January, when we’ll update the Covid Resilience Ranking again.